相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Contributions of Immune Cells and Stromal Cells to the Pathogenesis of Systemic Sclerosis: Recent Insights
Bingying Dai et al.
FRONTIERS IN PHARMACOLOGY (2022)
Single Cell RNA Sequencing in Autoimmune Inflammatory Rheumatic Diseases: Current Applications, Challenges and a Step Toward Precision Medicine
Tadeja Kuret et al.
FRONTIERS IN MEDICINE (2022)
Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches
Devis Benfaremo et al.
BIOMEDICINES (2022)
PDGF receptor mutations in human diseases
Emilie Guerit et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Scleroderma epidemiology update
Leonardo Martin Calderon et al.
CURRENT OPINION IN RHEUMATOLOGY (2021)
Tyrosine kinases in the pathogenesis of tissue fibrosis in systemic sclerosis and potential therapeutic role of their inhibition
Fabian A. Mendoza et al.
TRANSLATIONAL RESEARCH (2021)
Structures of HCMV Trimer reveal the basis for receptor recognition and cell entry
Marc Kschonsak et al.
CELL (2021)
PDGF Promotes Dermal Fibroblast Activation via a Novel Mechanism Mediated by Signaling Through MCHR1
Naoko Takamura et al.
FRONTIERS IN IMMUNOLOGY (2021)
PDGF-BB promotes vascular smooth muscle cell migration by enhancing Pim-1 expression via inhibiting miR-214
Jinshan Zhou et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Novel Concepts in Systemic Sclerosis Pathogenesis: Role for miRNAs
Iulia Szabo et al.
BIOMEDICINES (2021)
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study
Jelena Blagojevic et al.
CLINICAL RHEUMATOLOGY (2020)
The emerging complexity of PDGFRs: activation, internalization and signal attenuation
Madison A. Rogers et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2020)
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
Athol U Wells et al.
Lancet Respiratory Medicine (2020)
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas The ANNOUNCE Randomized Clinical Trial
William D. Tap et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Natascha Roehlen et al.
CELLS (2020)
CXCL4 triggers monocytes and macrophages to produce PDGF-BB, culminating in fibroblast activation: Implications for systemic sclerosis
Maarten van der Kroef et al.
JOURNAL OF AUTOIMMUNITY (2020)
Circulating biomarkers of systemic sclerosis - interstitial lung disease
Anna-Maria Hoffmann-Vold et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2020)
Pathogenesis of systemic sclerosis associated interstitial lung disease
Svetlana Nihtyanova et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2020)
Notch Signaling Activity Determines Uptake and Biological Effect of Imatinib in Systemic Sclerosis Dermal Fibroblasts
Saliha Harrach et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin
Fiorenza Orlando et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2019)
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
K. R. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Shared and distinct mechanisms of fibrosis
Joerg H. W. Distler et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
Agonistic antibodies in systemic sclerosis
Gianluca Moroncini et al.
IMMUNOLOGY LETTERS (2018)
PDGF in organ fibrosis
Barbara Mara Klinkhammer et al.
MOLECULAR ASPECTS OF MEDICINE (2018)
The PDGF/PDGFR pathway as a drug target
Natalia Papadopoulos et al.
MOLECULAR ASPECTS OF MEDICINE (2018)
Developments in the management of advanced soft-tissue sarcoma - olaratumab in context
Gianluca Moroncini et al.
ONCOTARGETS AND THERAPY (2018)
Different PDGF Receptor Dimers Drive Distinct Migration Modes of the Mouse Skin Fibroblast
Kohta Yamada et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Update of EULAR recommendations for the treatment of systemic sclerosis
Otylia Kowal-Bielecka et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Genomic and genetic studies of systemic sclerosis: A systematic review
Paraskevi Chairta et al.
HUMAN IMMUNOLOGY (2017)
Blockade of PDGF Receptors by Crenolanib Has Therapeutic Effect in Patient Fibroblasts and in Preclinical Models of Systemic Sclerosis
Katsunari Makino et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Pathogenetic significance and possibility as a therapeutic target of platelet derived growth factor
Yoko Ishii et al.
PATHOLOGY INTERNATIONAL (2017)
Structure of the Full-length VEGFR-1 Extracellular Domain in Complex with VEGF-A
Sandra Markovic-Mueller et al.
STRUCTURE (2017)
Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease
Viktor Martyanov et al.
PLOS ONE (2017)
Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities
John Varga et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2017)
Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach
Gianluca Moroncini et al.
ANALYTICAL BIOCHEMISTRY (2017)
Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis
Jingang Huang et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Structural and biochemical studies of the PDGFRA kinase domain
Ling Liang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
PDGF-A and PDGF-B induces cardiac fibrosis in transgenic mice
Radiosa Gallini et al.
EXPERIMENTAL CELL RESEARCH (2016)
Intronic polyadenylation of PDGFRα in resident stem cells attenuates muscle fibrosis
Alisa A. Mueller et al.
NATURE (2016)
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti-Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies
Michele M. Luchetti et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Characterization of Binding Mode of Action of a Blocking Anti-Platelet-Derived Growth Factor (PDGF)-B Monoclonal Antibody, MOR8457, Reveals Conformational Flexibility and Avidity Needed for PDGF-BB To Bind PDGF Receptor-beta
Jun Kuai et al.
BIOCHEMISTRY (2015)
Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial
Jessica K. Gordon et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Multiplex cytokine analysis of dermal interstitial blister fluid defines local disease mechanisms in systemic sclerosis
Kristina E. N. Clark et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Epitope Specificity Determines Pathogenicity and Detectability of Anti-Platelet-Derived Growth Factor Receptor Autoantibodies in Systemic Sclerosis
Gianluca Moroncini et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study
Paolo Fraticelli et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Platelet-derived growth factors and their receptors: Structural and functional perspectives
Po-Han Chen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2013)
Inhibition of platelet-derived growth factor-AB signaling prevents electromechanical remodeling of adult atrial myocytes that contact myofibroblasts
Hassan Musa et al.
HEART RHYTHM (2013)
Alteration of circulating miRNAs in SSc: miR-30b regulates the expression of PDGF receptor β
Shigeru Tanaka et al.
RHEUMATOLOGY (2013)
Platelet-derived growth factor alpha and beta receptors have overlapping functional activities towards fibroblasts
Johanna Donovan et al.
FIBROGENESIS & TISSUE REPAIR (2013)
Stromal Platelet-Derived Growth Factor Receptor α (PDGFRα) Provides a Therapeutic Target Independent of Tumor Cell PDGFRα Expression in Lung Cancer Xenografts
David E. Gerber et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Recent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathy
Hetian Lei et al.
EXPERIMENTAL EYE RESEARCH (2010)
Autoantibody profiles in systemic sclerosis: Predictive value for clinical evaluation and prognosis
Yasuhito Hamaguchi
JOURNAL OF DERMATOLOGY (2010)
Structures of a platelet-derived growth factor/propeptide complex and a platelet-derived growth factor/receptor complex
Ann Hye-Ryong Shim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Increased PDGFRα Activation Disrupts Connective Tissue Development and Drives Systemic Fibrosis
Lorin E. Olson et al.
DEVELOPMENTAL CELL (2009)
BIBF 1120: Triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy
Frank Hilberg et al.
CANCER RESEARCH (2008)
Role of platelet-derived growth factors in physiology and medicine
Johanna Andrae et al.
GENES & DEVELOPMENT (2008)
Pathogenic autoantibodies in systemic sclerosis
Armando Gabrielli et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor
Satoru Yuzawa et al.
CELL (2007)
Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis
Joerg H. W. Distler et al.
ARTHRITIS AND RHEUMATISM (2007)
PDGF signaling in cells and mice
M Tallquist et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
Regulation of c-myc expression by PDGF through Rho GTPases
M Chiariello et al.
NATURE CELL BIOLOGY (2001)
分享论文
